Advertisement
Singapore markets closed

  • Straits Times Index

    3,300.00
    -4.00 (-0.12%)
     

  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     

  • Dow

    38,834.86
    +56.76 (+0.15%)
     

  • Nasdaq

    17,862.23
    +5.21 (+0.03%)
     

  • Bitcoin USD

    66,255.02
    +1,006.44 (+1.54%)
     

  • CMC Crypto 200

    1,374.50
    -8.17 (-0.59%)
     

  • FTSE 100

    8,231.58
    +26.47 (+0.32%)
     

  • Gold

    2,352.30
    +5.40 (+0.23%)
     

  • Crude Oil

    81.73
    +0.16 (+0.20%)
     

  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     

  • Nikkei

    38,633.02
    +62.26 (+0.16%)
     

  • Hang Seng

    18,335.32
    -95.07 (-0.52%)
     

  • FTSE Bursa Malaysia

    1,592.69
    -7.10 (-0.44%)
     

  • Jakarta Composite Index

    6,819.32
    +92.40 (+1.37%)
     

  • PSE Index

    6,344.56
    -21.47 (-0.34%)
     

Schrödinger to Present at Jefferies Global Healthcare Conference

Business Wire
·1-min read

NEW YORK, May 22, 2024--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wednesday, June 5, 2024, at 2:30 p.m. ET.

The live webcast can be accessed in the "Investors" section of Schrödinger’s website and will be archived for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

ADVERTISEMENT

Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522086641/en/

Contacts

Allie Nicodemo
Schrödinger, Inc.
allie.nicodemo@schrodinger.com
617-356-2325